1167 — Jacobio Pharmaceuticals Co Balance Sheet
0.000.00%
- HK$5.49bn
- HK$4.48bn
- CNY155.71m
Annual balance sheet for Jacobio Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,627 | 1,538 | 1,284 | 1,143 | 1,175 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 187 | 97.6 | 40.1 | 20.6 | 14.1 |
| Total Other Current Assets | |||||
| Total Current Assets | 1,815 | 1,640 | 1,339 | 1,168 | 1,189 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 34.1 | 41.8 | 205 | 220 | 151 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,867 | 1,722 | 1,575 | 1,460 | 1,359 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 73.9 | 80.8 | 156 | 205 | 243 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 81.2 | 84.7 | 292 | 387 | 436 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,786 | 1,637 | 1,283 | 1,073 | 923 |
| Total Liabilities & Shareholders' Equity | 1,867 | 1,722 | 1,575 | 1,460 | 1,359 |
| Total Common Shares Outstanding |